Background Serum carcinoembryonic antigen (CEA) is an important biomarker for
diagnosis, prognosis, recurrence, metastasis monitoring, and the evaluation of the effect of …

Background Circulating biomarkers may be of value in providing additional prognostic
information to the TNM staging system. Previous population‐level studies suggest a …

The incidence rate of esophagogastric junction (EGJ) adenocarcinoma has been rapidly
increasing worldwide. Carcinoembryonic antigen (CEA) and carbohydrate antigen 19‐9 (CA …

Introduction Recent reports have reopened discussion of the prognostic value of elevated
pre-treatment carcinoembryonic antigen (CEA) levels in colorectal cancer. Due to the …

Purpose Peritoneal recurrence is not an uncommon cause of death after surgery for gastric
cancer, even after surgery with curative intent. This indicates that there is undetected …

Preoperative carcinoembryonic antigen elevation in colorectal cancer. - Abstract - Europe
PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools Developers …

Purpose: The purpose of this research is to investigate the clinical usefulness of
carcinoembryonic antigen (CEA) expression in colorectal cancer tissue. Methods: We …

Background and Aims Carcinoembryonic antigen (CEA) is the most commonly used tumor
marker for gastrointestinal cancers but its value for resectable gastric adenocarcinoma …

BACKGROUND: We evaluated factors associated with an increased preoperative
carcinoembryonic antigen (CEA) level for colon cancer patients undergoing elective curative …

Purpose The aim of this study was to evaluate whether the perioperative carcinoembryonic
antigen (CEA) ratio could be used as a determinant for adjuvant therapy after curative …